BeiGene USA was granted orphan designation from the FDA for a treatment of mantle cell lymphoma, according to a post to the agency’s website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BGNE:
